Inexium

Esomeprazole, the active ingredient in Inexium, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid production and is used to manage conditions such as gastro‑oesophageal reflux disease, erosive oesophagitis, NSAID‑induced ulcers and Zollinger‑Ellison syndrome.

GNH USA supplies Inexium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Inexium (esomeprazole) is indicated for several acid‑related gastrointestinal conditions: - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and regurgitation by maintaining higher gastric pH. - Erosive oesophagitis: promotes healing of damaged esophageal lining and prevents further erosion. - NSAID‑induced gastric ulcer: protects the gastric mucosa by reducing acid exposure. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.

Adverse reactions to esomeprazole are generally mild, but serious events can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools, usually transient. - Nausea: occasional feeling of queasiness. - Abdominal pain: discomfort in the stomach area. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent diarrhea with abdominal pain. - Low magnesium levels: muscle cramps, irregular heartbeat, or seizures. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: signs of hepatic dysfunction.

When prescribing esomeprazole, clinicians should consider several precautionary measures to ensure safe use. - Assess renal function: dose adjustment may be needed in severe impairment. - Evaluate for CYP2C19 polymorphism: altered metabolism can affect drug levels. - Monitor long‑term use: prolonged therapy may increase risk of fractures and infections. - Use with caution in elderly: higher susceptibility to adverse events. - Review concomitant medications: potential for drug‑drug interactions. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in original packaging.

Esomeprazole can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Ketoconazole: reduced absorption leading to therapeutic failure. - Atazanavir: decreased plasma concentrations compromising antiviral efficacy. - Warfarin: increased anticoagulant effect, raising bleeding risk.

Moderate Interactions (Monitor Closely): - Clopidogrel: reduced activation may diminish antiplatelet activity. - Digoxin: increased serum levels may cause toxicity. - Methotrexate (high dose): elevated exposure can enhance toxicity. - Phenytoin: decreased levels may reduce seizure control.